Prof. James C. Warf, a Manhattan Project chemist, author and activist, died last week.
An early member of the Federation of American Scientists, Dr. Warf held patents on the separation of plutonium from high-level nuclear waste. He taught chemistry at the University of Southern California for forty years, specializing in rare earth metals. He also taught for ten years in Indonesia and Brunei and, his son recalled, he wrote the first textbooks on organic and inorganic chemistry in the Indonesian language. He was a skilled amateur vintner and happily gave away samples of his product.
Dr. Warf also gave generously of his time and expertise to public interest groups concerned with nuclear weapons and nuclear reactor safety. He was a fundamentally decent man.
He was remembered in “James C. Warf dies at 91; Manhattan Project chemist became peace activist, USC professor” by Claire Noland, Los Angeles Times, November 9.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.